(Q84142639)

English

Lp-PLA(2) and risk of atherosclerotic vascular disease

scientific article published on 01 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lp-PLA(2) and risk of atherosclerotic vascular disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

vascular disease

1 reference

based on heuristic

inferred from title

author name string

Robert S Rosenson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

1 May 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

375

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

9725

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1498-1500

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein-associated phospholipase A(2) and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960488-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60488-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435213%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84142639&oldid=1650271794"